Astrazeneca PLC stock price

Astrazeneca PLC latest news:


  • 02/18/2018 22:49:55

    UK Stocks-Factors to watch on Feb 19

    Feb 19 (Reuters) - Britain's FTSE 100 index is seen opening 12 points higher at 7,306.4 on Monday, according to financial bookmakers. * ASTRAZENECA: The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc's immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can't be surgically removed. * ACACIA MINING: Gold miner Acacia Mining confirmed on Friday it had begun to value its Tanzanian operations for a potentia

  • 02/16/2018 15:18:56

    U.S. FDA approves AstraZeneca's immunotherapy for lung cancer

    The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc's (AZN), immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can't be surgically removed. The approval was based on a trial testing on 713 patients whose cancer had not progressed after chemotherapy and radiation.

  • 02/02/2018 00:17:03

    AstraZeneca flags return to drug sales growth in 2018

    LONDON, Feb 2 (Reuters) - AstraZeneca expects to increase drug sales at a low single-digit percentage rate this year as new medicines win market share and the company puts patent losses behind it, although the need to invest in launches will weigh on profit.

  • 02/01/2018 15:52:22

    AstraZeneca is sued by Array BioPharma over cancer drug royalties

    Array BioPharma Inc(ARRY) on Thursday sued AstraZeneca AB, accusing the pharmaceutical company of refusing to pay required royalties for a cancer drug after entering into an $8.5 billion collaboration with Merck & Co. In a complaint filed in the New York State Supreme Court in Manhattan, Array is seeking at least $192 million from AstraZeneca (AZN) for the alleged breach of a 2003 licensing agreement relat...

  • 01/26/2018 00:54:17

    UPDATE 1-UK Stocks-Factors to watch on Jan 26

    (Adds company news item, futures) Jan 26 (Reuters) - Britain's FTSE 100 index is seen opening 23 points higher at 7,638.4 on Friday, according to financial bookmakers, with futures up 0.20 percent ahead of the cash market open. * ASTRAZENECA: AstraZeneca said its inhaler for chronic obstructive pulmonary disease (COPD) showed improved lung function in a late stage trial that could challenge GlaxoSmithKline's new three-in-one inhaler.

  • 01/18/2018 17:04:58

    At AstraZeneca, fewer drug projects bring big productivity jump

    LONDON (Reuters) - A focus on fewer diseases, together with cuts in laboratories and staff, has delivered a more than fourfold increase in research productivity at drugmaker AstraZeneca , based on one key measure of success. The analysis published on Friday comes at a time of soul-searching among large pharmaceutical companies as they compete with smaller biotech firms, which are getting new drugs to market more efficiently. The turnaround evident this decade at AstraZeneca fo

  • 12/29/2017 07:01:19

    Top Analyst Upgrades and Downgrades: American Water Works, JB Hunt, Ford, GM, AstraZeneca and More


  • 12/18/2017 00:18:25

    BRIEF-US FDA Accepts Tagrisso Submission For 1St-Line Nsclc

    Astrazeneca Plc(AZN): * FDA ACCEPTS TAGRISSO SUBMISSION FOR 1ST-LINE NSCLC. * ‍US FDA ACCEPTS REGULATORY SUBMISSION FOR TAGRISSO IN 1ST-LINE EGFR-MUTATED NON-SMALL CELL LUNG CANCER​ Source text for Eikon: Further company coverage:

  • 11/27/2017 00:07:16

    AstraZeneca steps up China push with new drug joint venture

    LONDON (Reuters) - Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new drug development joint venture with a state-backed private equity fund.

  • More trends:

    AT&T Inc.T | Atento S.A.ATTO | Atlantic Power CorporationAT | Atlas EnergyATLS | Atlas Resource PartnersARP | Atlas Resource PartnersARP^D | Atlas Resource PartnersARP^E | Atmos Energy CorporationATO | Atwood OceanicsATW | AU Optronics CorpAUO |